PA2G4-MYC signaling axis involved in pathogenesis of 3q26 AML, study shows

June 26, 2024

The treatment of subtypes of acute myeloid leukemia (AML) characterized by aberrantly activated transcription factors is still challenging.

BioWorld Science Conferences European Hematology Association Cancer

Today's news in brief

BioWorld

BioWorld briefs for May 13, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for May 13, 2025.

FDA shift from animal testing fuels organoid, organ-on-chip demand

BioWorld Science

The U.S. FDA’s decision to phase out animal testing for INDs is driving a new market of alternative, nonanimal testing technologies like organoids and...

AI generated, 3D rendering of protein degradation

AACR 2025: Induced proximity strategy, beyond degraders

BioWorld

Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...

Neuroplastin 65 knockout disrupts visual function by altering the retina

BioWorld Science

Researchers from Tongji University School of Medicine and collaborating institutions have discovered that NP65 plays a crucial role in maintaining normal visual...